MedPath

Treatment Protocol and Long-Term Outcomes in Craniofacial Fibrous Dysplasia

Completed
Conditions
Craniofacial Fibrous Dysplasia
Registration Number
NCT06167122
Lead Sponsor
Chang Gung Memorial Hospital
Brief Summary

Craniofacial fibrous dysplasia (CFD) is a nonneoplastic disease characterized by fibro-osseous lesions in the affected bones. Treatment is mainly surgical and is stratified based on four different anatomical zones. This study aimed to evaluate the long-term outcomes and refine the algorithm for CFD.

Detailed Description

According to Chen et. al for the appropriate surgical management of FD the craniofacial skeleton can be divided into four zones according to the consideration of facial cosmesis, vital anatomical region and function preserving. The aim of the study was to evaluate the outcome of nearly 40 years long-term follow up cohort group and refine the algorithm of surgical intervention of FD under 4 zones classification.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
13
Inclusion Criteria
  • Received CFD surgical intervention between 1972 and 2019
  • Personal interviews: between late 2019 and 2020, covering a postoperative period of over 20 years
  • All the surgery were performed by a senior surgeon (Yu-Ray Chen) at Chang Gung Craniofacial Center
Exclusion Criteria
  • Patients who underwent surgical treatment at other institutions during the follow-up period or those who did not return to the craniofacial outpatient department for follow-up and receive computed tomography scans between 2019 and 2020 will be excluded.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
RecurrencePersonal interviews with facial bone computed tomography obtained on late 2019 and 2020

Recurrence based on facial bone computed tomography

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chang Gung Memorial Hospital

🇨🇳

Taoyuan, Taiwan

Chang Gung Memorial Hospital
🇨🇳Taoyuan, Taiwan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.